Algorae Pharmaceuticals Limited operates as a clinical-stage pharmaceutical company. The Company focuses on research and development programs to accelerate patient access to novel drugs and therapies using the latest technologies and scientific innovations. Algorae Pharmaceuticals offers its services worldwide.

Significant Cardioprotection Qualities in AI-168 Studies

Appointment of Pharmaceutical Executive

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Algorae Pharmaceuticals (1AI AU)

Significant Cardioprotection Qualities in AI-168 Studies

Appointment of Pharmaceutical Executive

24 New AI-Generated Drug Targets

Proposed issue of securities - 1AI

Appendix 3Y x2

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)